作者: FuGang Zhu , Yukui Li , Daqing Wang , Dong Yu , Lakshmi Bhagat
DOI:
关键词:
摘要: The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand agonist. may the prevention treatment cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin allergy, asthma disease caused by pathogen.